Sigyn Therapeutics Inc (SIGY)
5.25
0.00 (0.00%)
USD |
OTCM |
Jun 24, 16:00
Sigyn Therapeutics 1 Year Total Returns (Daily): 31.25% for June 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 25, 2024 | 31.25% |
| June 24, 2024 | 31.25% |
| June 21, 2024 | 75.00% |
| June 20, 2024 | 152.4% |
| June 18, 2024 | 87.50% |
| June 17, 2024 | 87.50% |
| June 14, 2024 | 87.50% |
| June 13, 2024 | 54.41% |
| June 12, 2024 | 54.41% |
| June 11, 2024 | 54.41% |
| June 10, 2024 | 54.41% |
| June 07, 2024 | 44.23% |
| June 06, 2024 | 44.23% |
| June 05, 2024 | 87.50% |
| June 04, 2024 | 87.50% |
| June 03, 2024 | 87.50% |
| May 31, 2024 | 31.25% |
| May 30, 2024 | 15.14% |
| May 29, 2024 | 15.14% |
| May 28, 2024 | 15.14% |
| May 24, 2024 | 15.14% |
| May 23, 2024 | 15.14% |
| May 22, 2024 | 15.14% |
| May 21, 2024 | 15.14% |
| May 20, 2024 | 15.14% |
| Date | Value |
|---|---|
| May 17, 2024 | 15.14% |
| May 16, 2024 | 15.14% |
| May 15, 2024 | 18.24% |
| May 14, 2024 | -17.13% |
| May 13, 2024 | -17.13% |
| May 10, 2024 | -17.13% |
| May 09, 2024 | -17.13% |
| May 08, 2024 | -17.13% |
| May 07, 2024 | -17.13% |
| May 06, 2024 | -12.99% |
| May 03, 2024 | -12.99% |
| May 02, 2024 | -12.99% |
| May 01, 2024 | -8.84% |
| April 30, 2024 | 16.50% |
| April 29, 2024 | 23.11% |
| April 26, 2024 | 23.11% |
| April 25, 2024 | 11.65% |
| April 24, 2024 | 11.65% |
| April 23, 2024 | 11.65% |
| April 22, 2024 | 11.65% |
| April 19, 2024 | 11.65% |
| April 18, 2024 | 6.80% |
| April 17, 2024 | 18.45% |
| April 16, 2024 | 18.45% |
| April 15, 2024 | 18.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.89%
Minimum
Aug 24 2020
790.9%
Maximum
Aug 19 2021
-18.06%
Average
-46.11%
Median
1 Year Total Returns (Daily) Benchmarks
| CEL-SCI Corp | -46.75% |
| AIM ImmunoTech Inc | -18.82% |
| IGC Pharma Inc | 40.06% |
| NovaBay Pharmaceuticals Inc | -92.50% |
| Protalix BioTherapeutics Inc | -42.41% |